{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-23-000054","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.811359+00:00","generated_at":"2026-06-08T08:06:10.739722+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Apyx Medical Q3 revenue up 31% to $12.0M; cuts FY2023 revenue guidance sharply","bullets":["Q3 Advanced Energy revenue $9.8M (+39%); total revenue $12.0M (+31%); net loss $4.6M improved 20% YoY.","Cuts FY2023 revenue guidance to $53-54M from $59-62M; Advanced Energy now $44.5-45.5M from $51-54M.","Secured $45M credit facility with Perceptive; initial $37.5M funded; used to repay MidCap debt.","CFO Tara Semb to leave; successor identified but not named; departure not due to disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-23-000054","json":"https://secwatch.observer/filing/0000719135-23-000054.json","markdown":"https://secwatch.observer/filing/0000719135-23-000054.md","text":"https://secwatch.observer/filing/0000719135-23-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000054/0000719135-23-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000054/apyx-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T08:06:10.739722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"095d5bf340b4bb19f240deb6e717888288b303e3","claim":"Apyx Medical Corp reported the third quarter ended September 30, 2023 results: revenue $12.0 million, net income Net loss attributable to stockholders of $4.6 million. Guidance reaffirmed.","evidence_excerpt":"quarter ended September 30, 2023, and updated its financial expectations for the full year ending December 31, 2023. Third Quarter 2023 Financial Summary : • Total revenue of $12.0 million, up 31% year-over-year. ◦ Advanced Energy revenue of $9.8 million, up 39% year-over-year. ◦ OEM revenue of $2.1 million, up 5% year-over-year. • Net loss attributable to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000054/0000719135-23-000054-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"$12.0 million"},{"label":"Net income","value":"Net loss attributable to stockholders of $4.6 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}